Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected

Objective Sepsis is one of the leading causes of the deaths in hospitals. During sepsis, patients are exposed to endotoxemia, which may contribute to the dysregulation of the immune system frequently observed in sepsis. This dysregulation leads to impaired pro-inflammatory responses and may increase the risk for secondary infections in sepsis. The experimental human endotoxemia model is widely used as a model system to study the acute effects of endotoxemia. Under physiological circumstances, the immune system is tightly regulated. Effector T-cells exert pro-inflammatory function and are restrained by regulatory T-cells (Tregs), which modulate pro-inflammatory effector responses. Endotoxemia may induce inadequate Treg activity or render effector T-cells dysfunctional. It was the aim of the study to investigate effector T-cell and Treg responses in an experimental human endotoxemia model. Methods In a cross-over designed placebo-controlled study, 20 healthy male volunteers received an intravenous injection of either lipopolysaccharide (LPS) (0.8 ng/kg body weight) or a placebo (saline 0.9%). CD3+ T-cells, CD4+ T-cells, CD8+ T-cells, and intracellular cytokine profiles were measured with flow cytometry at baseline and at repeated points after LPS/placebo injection. Complete blood cell counts were obtained with an automated hematology analyzer and cytokines were quantified by ELISA. Results Circulating neutrophils were significantly increased 2 h after LPS injection (p < 0.001) while absolute number of CD3+ T-cells, CD4+ T-cells, and CD8+ T-cells decreased (p < 0.001). Effector T-helper-cells (THs) showed a significant—but transient—decrease of pro-inflammatory IFNγ, interleukin (IL)-2, TNFα, and IL-17A production after LPS injection (p < 0.001). In contrast, the frequency of Treg and the capacity to produce IL-10 were unchanged (p = 0.21). Conclusion Effector THs fail to produce pro-inflammatory Th1-/Th17-associated cytokines after LPS challenge. In contrast, IL-10 production by Treg is not affected. Thus, endotoxemia-induced suppression of pro-inflammatory THs might be considered as a contributing factor to immunoparalysis in sepsis.

[1]  M. Netea,et al.  Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo , 2017, Front. Immunol..

[2]  M. Netea,et al.  The immunopathology of sepsis and potential therapeutic targets , 2017, Nature Reviews Immunology.

[3]  H. Engler.  Entzündung und Depression , 2017 .

[4]  R. Gold,et al.  Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms , 2017, Molecular Psychiatry.

[5]  P. Pickkers,et al.  Characterization of a model of systemic inflammation in humans in vivo elicited by continuous infusion of endotoxin , 2017, Scientific Reports.

[6]  H. Ullum,et al.  Inflammation-Induced Changes in Circulating T-Cell Subsets and Cytokine Production During Human Endotoxemia , 2017, Journal of intensive care medicine.

[7]  Ø. Salvesen,et al.  Activation of innate immune genes in caprine blood leukocytes after systemic endotoxin challenge , 2016, BMC Veterinary Research.

[8]  G. Maurer,et al.  Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans , 2016, Scientific Reports.

[9]  Christopher W Seymour,et al.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[10]  S. Elsenbruch,et al.  Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms , 2016, Brain, Behavior, and Immunity.

[11]  K. Selmaj,et al.  Induction of human IL-10-producing neutrophils by LPS-stimulated Treg cells and IL-10 , 2015, Mucosal Immunology.

[12]  P. Pickkers,et al.  Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options. , 2015, Minerva anestesiologica.

[13]  H. Engler,et al.  Endotoxin-induced experimental systemic inflammation in humans: A model to disentangle immune-to-brain communication , 2014, Brain, behavior, and immunity.

[14]  M. Netea,et al.  Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? , 2013, American journal of respiratory and critical care medicine.

[15]  L. Joosten,et al.  Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. , 2012, American journal of respiratory and critical care medicine.

[16]  M. Netea,et al.  Deficient Candida-specific T-helper 17 response during sepsis. , 2012, The Journal of infectious diseases.

[17]  R. Hotchkiss,et al.  Immunosuppression in patients who die of sepsis and multiple organ failure. , 2011, JAMA.

[18]  O. Wolf,et al.  Dose-Dependent Effects of Endotoxin on Neurobehavioral Functions in Humans , 2011, PloS one.

[19]  M. Netea,et al.  Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia* , 2011, Critical care medicine.

[20]  J. Born,et al.  Selective Mobilization of Cytotoxic Leukocytes by Epinephrine , 2009, The Journal of Immunology.

[21]  V. Kuchroo,et al.  Interleukin-17 and type 17 helper T cells. , 2009, The New England journal of medicine.

[22]  A. Corthay,et al.  How do Regulatory T Cells Work? , 2009, Scandinavian journal of immunology.

[23]  T. van der Poll,et al.  In Vivo Lipopolysaccharide Exposure of Human Blood Leukocytes Induces Cross-Tolerance to Multiple TLR Ligands , 2009, The Journal of Immunology.

[24]  A. Balato,et al.  Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. , 2009, The Journal of investigative dermatology.

[25]  Stoyan Dimitrov,et al.  Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. , 2009, Blood.

[26]  A. Kessel,et al.  The role of T regulatory cells in human sepsis. , 2009, Journal of autoimmunity.

[27]  P. Pickkers,et al.  The effect of systemic iNOS inhibition during human endotoxemia on the development of tolerance to different TLR-stimuli , 2008, Innate immunity.

[28]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[29]  C. Chung,et al.  Regulatory T cell populations in sepsis and trauma , 2008, Journal of leukocyte biology.

[30]  T. van der Poll,et al.  Induction of IRAK-M Is Associated with Lipopolysaccharide Tolerance in a Human Endotoxemia Model , 2007, The Journal of Immunology.

[31]  Hema S Bashyam.  Th1/Th2 cross-regulation and the discovery of IL-10 , 2007, The Journal of experimental medicine.

[32]  T. Brezicka,et al.  CD4+CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients , 2007, European journal of immunology.

[33]  I. Cohen,et al.  Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. , 2006, The Journal of clinical investigation.

[34]  T. Delovitch,et al.  Regulatory lymphocytes: Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity , 2003, Nature Reviews Immunology.

[35]  R. Hotchkiss,et al.  Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1 , 2001, The Journal of Immunology.

[36]  T. van der Poll,et al.  Reduced Th1, but Not Th2, Cytokine Production by Lymphocytes after In Vivo Exposure of Healthy Subjects to Endotoxin , 2000, Infection and Immunity.

[37]  I. Cohen,et al.  Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling. , 2018, The Journal of clinical investigation.

[38]  T. van der Poll,et al.  UvA-DARE ( Digital Academic Repository ) Diminished interferon-gamma production and responsiveness after endotoxin administration to healthy humans , 2002 .